Structures by: Bartolucci G.
Total: 9
Dimesna
2Na,C4H8O6S42,3H2O
Acta Crystallographica Section E (2007) 63, 7 m1948-m1948
a=5.7328(2)Å b=10.9152(4)Å c=11.2665(4)Å
α=90.00° β=97.106(4)° γ=90.00°
3-Methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl 4-aminobenzoate
C18H13NO4
Acta Crystallographica Section E (2008) 64, 4 o718
a=7.6217(6)Å b=9.6142(7)Å c=10.6456(7)Å
α=101.618(6)° β=110.770(7)° γ=89.019(6)°
Diisopropyl{2-[2-(2-oxopyrrolidin-1-yl)acetamido]ethyl}ammonium hydrogen sulfate
C14H28N3O2,HO4S
Acta Crystallographica Section E (2008) 64, 6 o1160
a=6.7834(3)Å b=11.1755(4)Å c=12.9012(6)Å
α=72.165(4)° β=89.394(4)° γ=89.509(3)°
Irbesartan chloride 1.69-hydrate
C25H29N6O,Cl,1.69(H2O)
Acta Crystallographica Section E (2007) 63, 4 o1529-o1531
a=8.5557(3)Å b=25.0130(8)Å c=12.2675(4)Å
α=90.00° β=104.415(3)° γ=90.00°
2-(1,2,3,4-Tetrahydro-1-naphthyl)imidazolium chloride monohydrate
C13H15N2,Cl,H2O
Acta Crystallographica Section E (2010) 66, 9 o2321
a=9.82990(10)Å b=12.6671(2)Å c=10.5375(2)Å
α=90.00° β=92.6660(10)° γ=90.00°
4-Amino-<i>N</i>-(3-methoxypyrazin-2-yl)benzenesulfonamide
C11H12N4O3S
Acta Crystallographica Section E (2010) 66, 10 o2663
a=10.7589(2)Å b=9.5652(2)Å c=24.5586(4)Å
α=90.00° β=90.00° γ=90.00°
Torasemide methanol 0.25-solvate 0.25-hydrate
C16H20N4O3S1,0.25(CH4O),0.25(H2O)
Acta Crystallographica Section E (2009) 65, 5 o970-o971
a=16.8477(2)Å b=11.59510(10)Å c=20.3256(2)Å
α=90.00° β=108.6460(10)° γ=90.00°
Metoprolol succinate
C15H26N1O3,0.5(C4H4O42)
Acta Crystallographica Section E (2009) 65, 6 o1364-o1365
a=26.2630(4)Å b=7.9396(2)Å c=17.4629(4)Å
α=90.00° β=107.348(2)° γ=90.00°
Torasemide
C16H20N4O3S
Acta Crystallographica Section E (2009) 65, 5 o972-o973
a=11.33780(10)Å b=18.90550(10)Å c=16.49580(10)Å
α=90.00° β=94.2730(10)° γ=90.00°